Nutrition Science Partners Limited Report issue

For profit Phase 3
Founded: Shanghai China (2012)
Status: No NME R&D (2012)

Organization Overview

First Clinical Trial
2013
NCT01882764
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Nutrition Science Partners Limited

Active Ingredients

Drugs in Phase 3 Trials (1)

Andrographis paniculata (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Colitis (Phase 3)

Colitis, Ulcerative (Phase 3)

Crohn Disease (Phase 1)

Ulcer (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 2
  • # of Trial APIs: 1